Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors
MAO-B inhibitors are frequently used in the treatment of neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Due to the limited number of compounds available in this field, there is a need to develop new compounds. In the recent works, it was shown that various thiosemicarbazone derivati...
Saved in:
Main Authors: | Derya Osmaniye, Berkant Kurban, Begüm Nurpelin Sağlık, Serkan Levent, Yusuf Özkay, Zafer Asım Kaplancıklı |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/cfe17d4976e34513ab429bd9d92e62c3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibacterial and antifungal activity of some thiosemicarbazones and 1,3,4-thiadiazolines
by: Brousse,Beatriz N., et al.
Published: (2004) -
Synthesis, Antiproliferative and Antimalarial Activities of Dinuclear Silver(I) Complexes with Triphenylphosphine and Thiosemicarbazones Ligands
by: Nur Adila Fatin Mohd Khir, et al.
Published: (2021) -
Synthesis and crystal structure of a solvated CoIII complex with 2-hydroxy-3-methoxybenzaldehyde thiosemicarbazone ligands
by: Julia A. Rusanova, et al.
Published: (2021) -
Dioxomolybdenum(VI) complexes of ONN chelating thiosemicarbazones: Crystallographic and spectroscopic (UV, IR and NMR) studies
by: Songül EĞLENCE BAKIR
Published: (2021) -
Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis
by: Sumera Zaib, et al.
Published: (2021)